GlassScriptPhysician profile
Danielle Zheng
NPI 1215391800
$9,893.44
in general payments reported to CMS, 2019-2025
21 companies · $775 in 2025
The $775 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $241 · 2020: $6,697 · 2021: $571 · 2022: $197 · 2023: $480 · 2024: $933 · 2025: $775.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,188.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,187.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $4,267.67 | 2020 | |
| Abbott Laboratories | $3,283.01 | 2020-2025 | Proclaim, Infinity |
| Tersera Therapeutics LLC | $585.58 | 2022-2025 | Prialt |
| Nevro Corp. | $320.80 | 2019-2021 | |
| Boston Scientific Corporation | $241.05 | 2020-2025 | General - Pain Management |
| Medtronic, INC. | $240.72 | 2021-2025 | Inceptiv |
| Curonix LLC | $149.72 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Mml US, INC. | $129.00 | 2025 | Reactiv8 |
| Si-Bone, INC. | $102.59 | 2021 | |
| Stimwave Technologies Incorporated | $92.50 | 2020 | |
| Merz North America, INC. | $84.68 | 2020 | |
| Spr Therapeutics, INC | $67.98 | 2022 | |
| Merz Pharmaceuticals, LLC | $52.47 | 2021 | |
| Globus Medical, INC. | $51.47 | 2025 | Senza |
| Averitas Pharma INC. | $46.12 | 2024 | Qutenza |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanos Medical | $42.56 | 2021-2022 | |
| Nalu Medical, INC. | $35.96 | 2025 | Nalu Neurostimulation System |
| Vertex Pharmaceuticals Incorporated | $34.37 | 2025 | |
| Lundbeck LLC | $24.09 | 2020 | |
| Collegium Pharmaceutical, INC. | $23.92 | 2024 | Xtampza |
| Tonix Medicines, INC. | $17.18 | 2025 | Tonmya |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Zheng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.